SINO BIOPHARMACEUT HKD0.025 (SBMFF) Earns Underperform Rating from Analysts at Jefferies Group LLC
Jefferies Group LLC initiated coverage on shares of SINO BIOPHARMACEUT HKD0.025 (OTC:SBMFF) in a report released on Tuesday morning, StockTargetPrices.com reports. The brokerage issued an underperform rating on the stock.
Shares of SINO BIOPHARMACEUT HKD0.025 (OTC:SBMFF) opened at 0.82 on Tuesday. SINO BIOPHARMACEUT HKD0.025 has a 12-month low of $0.61 and a 12-month high of $0.89. The firm’s 50-day moving average is $0.78 and its 200 day moving average is $0.74. The stock has a market capitalization of $6.08 billion and a P/E ratio of 24.85.
TRADEMARK VIOLATION NOTICE: “SINO BIOPHARMACEUT HKD0.025 (SBMFF) Earns Underperform Rating from Analysts at Jefferies Group LLC” was first reported by Watch List News and is the sole property of of Watch List News. If you are viewing this piece of content on another publication, it was illegally copied and reposted in violation of US & international copyright and trademark law. The legal version of this piece of content can be viewed at http://www.watchlistnews.com/sino-biopharmaceut-hkd0-025-sbmff-earns-underperform-rating-from-analysts-at-jefferies-group-llc/1206352.html.
Receive News & Ratings for SINO BIOPHARMACEUT HKD0.025 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SINO BIOPHARMACEUT HKD0.025 and related companies with Analyst Ratings Network's FREE daily email newsletter.